Kai-Jun Zhu Pei-Dan Yang Qiang Xu
10.3389/fimmu.2021.695768
Front Immunol
2021 Jun 24;12:695768.
jak inhibitor case report cutaneous leukocytoclastic vasculitis inflammation tofacitinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/34248994/
Janus Kinase Inhibitors / therapeutic use Piperidines / therapeutic use Pyrimidines / therapeutic use Skin Ulcer / drug therapy Vasculitis, Leukocytoclastic, Cutaneous / drug therapy
Janus Kinase Inhibitors / therapeutic use Piperidines / therapeutic use Pyrimidines / therapeutic use Skin Ulcer / drug therapy Vasculitis, Leukocytoclastic, Cutaneous / drug therapy Case Reports Adult Drug Therapy, Combination Female Glucocorticoids / therapeutic use Humans Prednisone / therapeutic use Skin Ulcer / diagnosis Skin Ulcer / enzymology Treatment Outcome Vasculitis, Leukocytoclastic, Cutaneous / diagnosis Vasculitis, Leukocytoclastic, Cutaneous / enzymology Wound Healing / drug effects Glucocorticoids Janus Kinase Inhibitors Piperidines Pyrimidines tofacitinib Prednisone
PMC8264360
34248994
Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report
2021